Skip to search formSkip to main contentSkip to account menu

SR 49059

Known as: SR-49059, SR49059 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Significance In this study, we show that a primitive brain hormone, arginine vasopressin (AVP), which has hitherto been… 
Highly Cited
2013
Highly Cited
2013
We characterised the behavioural phenotype of mice heterozygous (Oxtr+/−) for the oxytocin receptor gene (Oxtr) and compared it… 
Highly Cited
2007
Highly Cited
2007
Intracellular retention of a functional vasopressin V2 receptor (V2R) is a major cause of congenital nephrogenic diabetes… 
Highly Cited
2005
Highly Cited
2005
In many mendelian diseases, some mutations result in the synthesis of misfolded proteins that cannot reach a transport-competent… 
Highly Cited
2004
Highly Cited
2004
Some membrane-permeable antagonists restore cell surface expression of misfolded receptors retained in the endoplasmic reticulum… 
Highly Cited
2004
Highly Cited
2004
In most cases, nephrogenic diabetes insipidus results from mutations in the V2 vasopressin receptor (V2R) gene that cause… 
Highly Cited
2004
Highly Cited
2004
Malignant growth of small-cell lung carcinoma is promoted by various neuroendocrine autocrine/paracrine loops. Therefore, to… 
Highly Cited
2002
Highly Cited
2002
Background and Purpose— Cerebral edema develops very early after the onset of focal cerebral ischemia and may be a major factor… 
Highly Cited
1993
Highly Cited
1993
SR 49059, a new potent and selective orally active, nonpeptide vasopressin (AVP) antagonist has been characterized in several in…